Evidence map›Paper›PMID 40434901›Full record

ArticleMolecular biology of the cell2025

Force-insensitive myosin-I enhances endocytosis robustness through actin network-scale collective ratcheting.

Michael A Ferrin, Ross T A Pedersen, David G Drubin, Matthew Akamatsu

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael A FerrinDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3220.
Ross T A PedersenDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3220.
David G DrubinDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3220.
Matthew AkamatsuDepartment of Biology, University of Washington, Seattle, WA 98195-1800.

Funding

Molecular and biophysical mechanism of plasma membrane internalization during nonclathrin endocytosisR00GM132551 · NIGMS · UNIVERSITY OF WASHINGTON · PI AKAMATSU, MATTHEW SATARO · 2023 to 2025
$747k
NIGMS NIH HHS R00 GM132551
6 · The paper itself

Abstract

Force production by type-I myosins influences endocytic progression in many cell types. Because different myosin-I isoforms exhibit distinct force-dependent kinetic properties, it is important to investigate how these properties affect endocytic outcomes, and the mechanisms through which myosin-I contributes to endocytosis. To this end, we adapted our agent-based simulations of endocytic actin networks and incorporated nonprocessive, single-headed myosin motors at the base of the endocytic pit. We varied the unbinding rate and the force dependence of myosin unbinding. Our results revealed that the inclusion of myosin motors facilitated endocytic internalization, but only under kinetic regimes with rapid and less force-sensitive unbinding. Conversely, slow or strongly force-dependent unbinding impeded endocytic progression. As membrane tension increased, the boundary between assistive and inhibitory phases shifted, allowing the myosins to assist over larger regions of the kinetic landscape. Myosin-I's contribution to internalization could not be explained by direct force transduction or increased actin assembly. Instead, the myosins collectively bolstered the robustness of internalization by limiting pit retraction.

Indexed as

ActinsEndocytosisMyosin Type IActin CytoskeletonAnimalsBiomechanical PhenomenaCell MembraneKineticsModels, BiologicalActinsMyosin Type I

Identifiers

PMID40434901
PMCPMC12367308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.